Literature DB >> 2174303

Immunohistochemical demonstration of the placental form of glutathione S-transferase, a detoxifying enzyme in human gliomas.

A Hara1, H Yamada, N Sakai, H Hirayama, T Tanaka, H Mori.   

Abstract

Expression of the human placental form of glutathion S-transferase (GST-pi) in human gliomas was investigated by immunohistochemical methods, and the result was compared with that of normal human glial cells. The gliomas in this study were composed of five benign astrocytomas (Grade 2), ten anaplastic astrocytomas (Grade 3), and 16 glioblastomas (Grade 4). Normal human glial cells showed only a weak immunostaining response for GST-pi in the cytoplasm or some nuclear membranes. All of benign astrocytomas had diffusely weak GST-pi immunostaining, resembling that of normal glial cells. With increasing grade, gliomas showed a strongly positive reaction for GST-pi. The positive reactions were remarkable especially in the gemistocytes and giant cells in the high-grade gliomas. These results suggest that cells of gliomas have some detoxifying function and the expression of this detoxifying enzyme, GST-pi, is related to the degree of malignancy of the gliomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174303     DOI: 10.1002/1097-0142(19901215)66:12<2563::aid-cncr2820661219>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Expression of multidrug resistance-associated protein (MRP) in human gliomas.

Authors:  M Mohri; H Nitta; J Yamashita
Journal:  J Neurooncol       Date:  2000-09       Impact factor: 4.130

2.  Glutathione S-Transferases and Cytochrome P450 Enzyme Expression in Patients with Intracranial Tumors: Preliminary Report of 55 Patients.

Authors:  Cahit Kural; Arzu Kaya Kocdogan; Gulcin Güler Şimşek; Serpil Oğuztüzün; Pınar Kaygın; Irmak Yılmaz; Tugbag Bayram; Yusuf Izci
Journal:  Med Princ Pract       Date:  2018-10-15       Impact factor: 1.927

3.  Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.

Authors:  S Tanaka; H Kamitani; M R Amin; T Watanabe; H Oka; K Fujii; T Nagashima; T Hori
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

4.  Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.

Authors:  A Korshunov; R Sycheva; V Timirgaz; A Golanov
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

5.  Identification of placental form of glutathione S-transferase in ACNU-resistant murine glioma cell lines.

Authors:  A Hara; S Niikawa; W Zhang; N Sakai; H Yamada; N Yoshimi; H Mori
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

6.  Expression of the placental form of glutathione S-transferase in pediatric gliomas.

Authors:  A Hara; N Sakai; H Yamada; S Niikawa; N Yoshimi; H Mori; K Shimokawa
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

7.  Glutathione S-transferases and cytochrome P450 detoxifying enzyme distribution in human cerebral glioma.

Authors:  R Grant; J W Ironside
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Inhibition of cell proliferation and glutathione S-transferase by ascorbyl esters and interferon in mouse glioma.

Authors:  A K Naidu; M Wiranowska; S H Kori; K C Roetzheim; A P Kulkarni
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

9.  Galectin-3 in preneoplastic lesions of glioma.

Authors:  Nguyen Huy Binh; Kunio Satoh; Kazuhiro Kobayashi; Manabu Takamatsu; Yuichiro Hatano; Akihiro Hirata; Hiroyuki Tomita; Toshiya Kuno; Akira Hara
Journal:  J Neurooncol       Date:  2012-11-23       Impact factor: 4.130

10.  Transcriptomic Profiling of 3D Glioblastoma Tumoroids for the Identification of Mechanisms Involved in Anticancer Drug Resistance.

Authors:  Nipha Chaicharoenaudomrung; Phongsakorn Kunhorm; Wilasinee Promjantuek; Narawadee Rujanapun; Nudjanad Heebkaew; Natchadaporn Soraksa; Parinya Noisa
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.